Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 427

1.

Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard.

Ribisl KM, Hatsukami DK, Huang J, Williams RS, Donny EC.

Am J Public Health. 2019 Jul;109(7):1007-1014. doi: 10.2105/AJPH.2019.305067.

PMID:
31166743
2.

Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects.

Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, Benowitz NL, Donny EC, Hecht SS.

Addiction. 2019 May 29. doi: 10.1111/add.14695. [Epub ahead of print]

PMID:
31140663
3.

Tobacco-Related Alterations in Airway Gene Expression are Rapidly Reversed Within Weeks Following Smoking-Cessation.

Hijazi K, Malyszko B, Steiling K, Xiao X, Liu G, Alekseyev YO, Dumas YM, Hertsgaard L, Jensen J, Hatsukami D, Brooks DR, O'Connor G, Beane J, Lenburg ME, Spira A.

Sci Rep. 2019 May 6;9(1):6978. doi: 10.1038/s41598-019-43295-3.

4.

Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

Carmella SG, Heskin AK, Tang MK, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami DK, Hecht SS.

PLoS One. 2019 Apr 25;14(4):e0215853. doi: 10.1371/journal.pone.0215853. eCollection 2019.

5.

Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures.

Mehrotra R, Yadav A, Sinha DN, Parascandola M, John RM, Ayo-Yusuf O, Nargis N, Hatsukami DK, Warnakulasuriya S, Straif K, Siddiqi K, Gupta PC.

Lancet Oncol. 2019 Apr;20(4):e208-e217. doi: 10.1016/S1470-2045(19)30084-1. Review.

PMID:
30942182
6.

"Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.

Khariwala SS, Rubin N, Stepanov I, Nollen N, Ahluwalia JS, Nelson HH, Hatsukami DK.

Head Neck. 2019 Jul;41(7):2332-2339. doi: 10.1002/hed.25708. Epub 2019 Feb 15.

PMID:
30770605
7.

Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Chang CM, Rostron BL, Chang JT, Corey CG, Kimmel HL, Sosnoff CS, Goniewicz ML, Edwards KC, Hatsukami DK, Wang Y, Del Valle-Pinero AY, Yang M, Travers MJ, Arnstein S, Taylor K, Conway K, Ambrose BK, Borek N, Hyland A, Wang L, Blount BC, van Bemmel DM.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):943-953. doi: 10.1158/1055-9965.EPI-18-0539. Epub 2019 Feb 7.

PMID:
30733305
8.

Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.

Goniewicz ML, Smith DM, Edwards KC, Blount BC, Caldwell KL, Feng J, Wang L, Christensen C, Ambrose B, Borek N, van Bemmel D, Konkel K, Erives G, Stanton CA, Lambert E, Kimmel HL, Hatsukami D, Hecht SS, Niaura RS, Travers M, Lawrence C, Hyland AJ.

JAMA Netw Open. 2018 Dec 7;1(8):e185937. doi: 10.1001/jamanetworkopen.2018.5937.

9.

Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Chen M, Carmella SG, Sipe C, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami D, Hecht SS.

PLoS One. 2019 Jan 4;14(1):e0210104. doi: 10.1371/journal.pone.0210104. eCollection 2019.

10.

Beliefs about E-cigarettes: A Focus Group Study with College Students.

Katz SJ, Erkinnen M, Lindgren B, Hatsukami D.

Am J Health Behav. 2019 Jan 1;43(1):76-87. doi: 10.5993/AJHB.43.1.7.

PMID:
30522568
11.

Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Wang Y, Wong LY, Meng L, Pittman EN, Trinidad DA, Hubbard KL, Etheredge A, Del Valle-Pinero AY, Zamoiski R, van Bemmel DM, Borek N, Patel V, Kimmel HL, Conway KP, Lawrence C, Edwards KC, Hyland A, Goniewicz ML, Hatsukami D, Hecht SS, Calafat AM.

Environ Int. 2019 Feb;123:201-208. doi: 10.1016/j.envint.2018.11.068. Epub 2018 Dec 6.

12.

Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study.

Patten CA, Koller KR, Flanagan CA, Hiratsuka VY, Hughes CA, Wolfe AW, Decker PA, Fruth K, Brockman TA, Korpela M, Gamez D, Bronars C, Murphy NJ, Hatsukami D, Benowitz NL, Thomas TK.

Patient Educ Couns. 2019 Mar;102(3):528-535. doi: 10.1016/j.pec.2018.10.009. Epub 2018 Oct 12.

13.

Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes.

Denlinger-Apte RL, Tidey JW, Koopmeiners JS, Hatsukami DK, Smith TT, Pacek LR, McClernon FJ, Donny EC.

Tob Control. 2019 May;28(3):352-355. doi: 10.1136/tobaccocontrol-2018-054622. Epub 2018 Nov 1.

PMID:
30385649
14.

Assessing the Impact of Conflicting Health Warning Information on Intentions to Use E-Cigarettes -An Application of the Heuristic-Systematic Model.

Katz SJ, Erkkinen M, Lindgren B, Hatsukami D.

J Health Commun. 2018;23(10-11):874-885. doi: 10.1080/10810730.2018.1533052. Epub 2018 Oct 25.

PMID:
30358500
15.

Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users.

Benowitz NL, Flanagan CA, Thomas TK, Koller KR, Wolfe AW, Renner CC, Hughes C, Decker PA, Hatsukami DK, Murphy NJ, Patten C.

Int J Circumpolar Health. 2018 Dec;77(1):1528125. doi: 10.1080/22423982.2018.1528125.

16.

The Debate About Nicotine Addiction and the Role of Medicinal Products: Commentary on Zeller.

Hatsukami DK, Donny EC.

Nicotine Tob Res. 2019 Feb 18;21(3):338-339. doi: 10.1093/ntr/nty195. No abstract available.

PMID:
30312443
17.

Reducing Nicotine in Cigarettes to Minimally Addictive Levels: A New Frontier for Tobacco Control.

Hatsukami DK.

JAMA Psychiatry. 2018 Oct 1;75(10):987-988. doi: 10.1001/jamapsychiatry.2018.1829. No abstract available.

PMID:
30285225
18.

E-cigarettes Warning Labels and Modified Risk Statements: Tests of Messages to Reduce Recreational Use.

Katz SJ, Lindgren B, Hatsukami D.

Tob Regul Sci. 2017 Oct;3(4):445-458. doi: 10.18001/TRS.3.4.6.

19.

Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.

Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, McClernon FJ, Murphy SE, Paiano V, Robinson JD, Severson H, Sipe C, Strasser AA, Strayer LG, Tang MK, Vandrey R, Hecht SS, Benowitz NL, Donny EC.

JAMA. 2018 Sep 4;320(9):880-891. doi: 10.1001/jama.2018.11473.

20.

Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers.

Murphy SE, Park SL, Balbo S, Haiman CA, Hatsukami DK, Patel Y, Peterson LA, Stepanov I, Stram DO, Tretyakova N, Hecht SS, Le Marchand L.

NPJ Precis Oncol. 2018 Aug 22;2:17. doi: 10.1038/s41698-018-0057-y. eCollection 2018. Review.

21.

Presence of the Carcinogen N'-Nitrosonornicotine in Saliva of E-cigarette Users.

Bustamante G, Ma B, Yakovlev G, Yershova K, Le C, Jensen J, Hatsukami DK, Stepanov I.

Chem Res Toxicol. 2018 Aug 20;31(8):731-738. doi: 10.1021/acs.chemrestox.8b00089. Epub 2018 Jul 30.

PMID:
30019582
22.

Cigarette and e-liquid demand and substitution in e-cigarette-naïve smokers.

Stein JS, Koffarnus MN, Stepanov I, Hatsukami DK, Bickel WK.

Exp Clin Psychopharmacol. 2018 Jun;26(3):233-243. doi: 10.1037/pha0000192.

23.

Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma.

Khariwala SS, Hatsukami DK, Stepanov I, Rubin N, Nelson HH.

JAMA Otolaryngol Head Neck Surg. 2018 Jun 1;144(6):477-482. doi: 10.1001/jamaoto.2018.0249.

24.

Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations.

Cassidy RN, Colby SM, Tidey JW, Jackson KM, Cioe PA, Krishnan-Sarin S, Hatsukami D.

Drug Alcohol Depend. 2018 Jul 1;188:153-160. doi: 10.1016/j.drugalcdep.2018.04.006. Epub 2018 May 16.

25.

Age Moderates Smokers' Subjective Response to Very Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial.

Cassidy RN, Tidey JW, Cao Q, Colby SM, McClernon FJ, Koopmeiners JS, Hatsukami D, Donny EC.

Nicotine Tob Res. 2018 Apr 28. doi: 10.1093/ntr/nty079. [Epub ahead of print]

PMID:
29718460
26.

Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.

Smith TT, Hatsukami DK, Benowitz NL, Colby SM, McClernon FJ, Strasser AA, Tidey JW, White CM, Donny EC.

Prev Med. 2018 Dec;117:8-14. doi: 10.1016/j.ypmed.2018.03.021. Epub 2018 Mar 29.

PMID:
29604326
27.

Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.

Dermody SS, McClernon FJ, Benowitz N, Luo X, Tidey JW, Smith TT, Vandrey R, Hatsukami D, Donny EC.

Exp Clin Psychopharmacol. 2018 Jun;26(3):223-232. doi: 10.1037/pha0000179. Epub 2018 Mar 5.

28.

Strong preference for mint snus flavor among research participants.

Schneller LM, Lindgren BR, Shields PG, Hatsukami DK, O'Connor RJ.

Addict Behav Rep. 2017 Jul 31;6:51-55. doi: 10.1016/j.abrep.2017.07.004. eCollection 2017 Dec.

29.

Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop.

Chang CM, Cheng YC, Cho TM, Mishina EV, Del Valle-Pinero AY, van Bemmel DM, Hatsukami DK.

Nicotine Tob Res. 2019 Jan 1;21(1):3-13. doi: 10.1093/ntr/ntx273.

PMID:
29253243
30.

Effects of Filter Ventilation on Behavioral Economic Demand for Cigarettes: A Preliminary Investigation.

Stein JS, Koffarnus MN, O'Connor RJ, Hatsukami DK, Bickel WK.

Nicotine Tob Res. 2018 Sep 4;20(10):1278-1282. doi: 10.1093/ntr/ntx164.

PMID:
29065197
31.

Consortium on Methods Evaluating Tobacco: Research Tools to Inform US Food and Drug Administration Regulation of Snus.

Berman ML, Bickel WK, Harris AC, LeSage MG, O'Connor RJ, Stepanov I, Shields PG, Hatsukami DK.

Nicotine Tob Res. 2018 Sep 25;20(11):1292-1300. doi: 10.1093/ntr/ntx228.

PMID:
29059363
32.

Hormonal contraceptive use in smokers: Prevalence of use and associations with smoking motives.

Allen AM, Lundeen K, Eberly LE, Allen SS, al'Absi M, Muramoto M, Hatsukami D.

Addict Behav. 2018 Feb;77:187-192. doi: 10.1016/j.addbeh.2017.10.011. Epub 2017 Oct 13.

33.

Use of hormonal contraceptives and smoking cessation: A preliminary report.

Allen AM, Carlson S, Eberly LE, Hatsukami D, Piper ME.

Addict Behav. 2018 Jan;76:236-242. doi: 10.1016/j.addbeh.2017.08.003. Epub 2017 Aug 4.

34.

Evaluating the utility of subjective effects measures for predicting product sampling, enrollment, and retention in a clinical trial of a smokeless tobacco product.

O'Connor RJ, Lindgren BR, Schneller LM, Shields PG, Hatsukami DK.

Addict Behav. 2018 Jan;76:95-99. doi: 10.1016/j.addbeh.2017.07.025. Epub 2017 Jul 14.

PMID:
28772248
35.

Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks.

Pacek LR, Joseph McClernon F, Denlinger-Apte RL, Mercincavage M, Strasser AA, Dermody SS, Vandrey R, Smith TT, Nardone N, Hatsukami DK, Koopmeiners JS, Kozink RV, Donny EC.

Tob Control. 2018 Jul;27(4):420-426. doi: 10.1136/tobaccocontrol-2017-053689. Epub 2017 Jul 22.

PMID:
28735272
36.

Tobacco Product Use Patterns, and Nicotine and Tobacco-Specific Nitrosamine Exposure: NHANES 1999-2012.

Choi K, Sabado M, El-Toukhy S, Vogtmann E, Freedman ND, Hatsukami D.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1525-1530. doi: 10.1158/1055-9965.EPI-17-0338. Epub 2017 Jul 14.

37.

High Level of Tobacco Carcinogen-Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers.

Khariwala SS, Ma B, Ruszczak C, Carmella SG, Lindgren B, Hatsukami DK, Hecht SS, Stepanov I.

Cancer Prev Res (Phila). 2017 Sep;10(9):507-513. doi: 10.1158/1940-6207.CAPR-17-0140. Epub 2017 Jul 5.

38.

Reducing tobacco-related harm: FDA's proposed product standard for smokeless tobacco.

Berman ML, Hatsukami DK.

Tob Control. 2018 May;27(3):352-354. doi: 10.1136/tobaccocontrol-2016-053612. Epub 2017 Jun 20.

39.

Sex differences in physiological response to the combination of stress and smoking.

Kotlyar M, Thuras P, Hatsukami DK, al'Absi M.

Int J Psychophysiol. 2017 Aug;118:27-31. doi: 10.1016/j.ijpsycho.2017.05.008. Epub 2017 May 23.

40.

Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Song MA, Benowitz NL, Berman M, Brasky TM, Cummings KM, Hatsukami DK, Marian C, O'Connor R, Rees VW, Woroszylo C, Shields PG.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx075. Review.

41.

Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use.

O'Connor RJ, Rees VW, Rivard C, Hatsukami DK, Cummings KM.

Subst Abus. 2017 Jul-Sep;38(3):330-336. doi: 10.1080/08897077.2017.1326999. Epub 2017 May 8.

42.

Cigarette Nicotine Content as a Moderator of the Relationship Between Negative Affect and Smoking.

Robinson JD, Kypriotakis G, Karam-Hage M, Green CE, Hatsukami DK, Cinciripini PM, Donny EC.

Nicotine Tob Res. 2017 Sep 1;19(9):1080-1086. doi: 10.1093/ntr/ntx068.

43.

Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.

Murphy SE, Sipe CJ, Choi K, Raddatz LM, Koopmeiners JS, Donny EC, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1093-1099. doi: 10.1158/1055-9965.EPI-16-0920. Epub 2017 Mar 6.

44.

Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms.

Kotlyar M, Lindgren BR, Vuchetich JP, Le C, Mills AM, Amiot E, Hatsukami DK.

Addict Behav. 2017 Aug;71:18-24. doi: 10.1016/j.addbeh.2017.02.018. Epub 2017 Feb 10.

45.

Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop.

Chang CM, Edwards SH, Arab A, Del Valle-Pinero AY, Yang L, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):291-302. doi: 10.1158/1055-9965.EPI-16-0675. Epub 2016 Nov 9.

46.

CYP2A6 metabolism in the development of smoking behaviors in young adults.

Olfson E, Bloom J, Bertelsen S, Budde JP, Breslau N, Brooks A, Culverhouse R, Chan G, Chen LS, Chorlian D, Dick DM, Edenberg HJ, Hartz S, Hatsukami D, Hesselbrock VM, Johnson EO, Kramer JR, Kuperman S, Meyers JL, Nurnberger J, Porjesz B, Saccone NL, Schuckit MA, Stitzel J, Tischfield JA, Rice JP, Goate A, Bierut LJ.

Addict Biol. 2018 Jan;23(1):437-447. doi: 10.1111/adb.12477. Epub 2016 Dec 29.

47.

Isotope Dilution nanoLC/ESI+-HRMS3 Quantitation of Urinary N7-(1-Hydroxy-3-buten-2-yl) Guanine Adducts in Humans and Their Use as Biomarkers of Exposure to 1,3-Butadiene.

Sangaraju D, Boldry EJ, Patel YM, Walker V, Stepanov I, Stram D, Hatsukami D, Tretyakova N.

Chem Res Toxicol. 2017 Feb 20;30(2):678-688. doi: 10.1021/acs.chemrestox.6b00407. Epub 2017 Jan 17.

48.

Developmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products.

England LJ, Aagaard K, Bloch M, Conway K, Cosgrove K, Grana R, Gould TJ, Hatsukami D, Jensen F, Kandel D, Lanphear B, Leslie F, Pauly JR, Neiderhiser J, Rubinstein M, Slotkin TA, Spindel E, Stroud L, Wakschlag L.

Neurosci Biobehav Rev. 2017 Jan;72:176-189. doi: 10.1016/j.neubiorev.2016.11.013. Epub 2016 Nov 24. Review.

49.

Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes.

Rupprecht LE, Koopmeiners JS, Dermody SS, Oliver JA, al'Absi M, Benowitz NL, Denlinger-Apte R, Drobes DJ, Hatsukami D, McClernon FJ, Pacek LR, Smith TT, Sved AF, Tidey J, Vandrey R, Donny EC.

Tob Control. 2017 Mar;26(e1):e43-e48. doi: 10.1136/tobaccocontrol-2016-053301. Epub 2016 Nov 17.

50.

Perceived risks and reasons to smoke cigarettes during pregnancy among Alaska native women.

Bronars C, Patten C, Koller K, Hatsukami D, Flanagan CA, Decker PA, Hanson A, Wolfe A, Hughes C, Benowitz N, Murphy NJ, Thomas T.

Ethn Health. 2018 Jan;23(1):33-42. doi: 10.1080/13557858.2016.1246425. Epub 2016 Nov 14.

Supplemental Content

Loading ...
Support Center